Hangzhou Gutuo Biotechnology Co., Ltd ga-esonye na ihe ngosi 21st CPHI World Pharmaceutical Raw Materials China na Shanghai, China na June 19, 2023, ụlọ ntu No. : N2F52.
"CPhI China" bụ ihe ngosi ọgwụ nke na-enye ngwọta jikọtara ọnụ maka ndị ọkachamara ụlọ ọrụ ọgwụ sitere na akụrụngwa ọgwụ, nhazi nkwekọrịta, biopharmacology, igwe ọgwụ, ihe nkwakọ ngwaahịa na ngwa ụlọ nyocha, ma gbasaa njikọ ụwa maka ụlọ ọrụ ọgwụ ụlọ.
Ihe ngosi ahụ na-ekpuchi ụlọ ọrụ na-emepụta ọgwụ, ndị na-ekesa / mbubata na mbupụ, ụlọ ọrụ na-ere ọgwụ, ụlọ ọrụ biopharma na nkà na ụzụ, igwe ọgwụ, nyocha nkwekọrịta na mmepe na mbupụ, nlekọta / ịzụ ahịa, nri na ihe ọṅụṅụ / nri ahụike / ụlọ ọrụ ịchọ mma, ụlọ nyocha. na akụrụngwa, yinye oyi na ngwa agha, nchekwa gburugburu ebe obibi na injinia, nkwakọ ngwaahịa / ụlọ ọrụ nnyefe ọgwụ, injinia ọgwụ, akpaaka / robots na mpaghara ndị ọzọ.
Ngwaahịa anyị gụnyekwara mmepụta nke peptide API intermediates, peptide CRO na CDMO ọrụ, mmepụta na nhazi mmepe nke peptides ịchọ mma, njikọ nke amino acids nchebe pụrụ iche na obere ogige molecule, nguzobe nke ọbá akwụkwọ peptide azụmahịa, na nkwado teknụzụ maka nyocha na mmepe ọgwụ ọhụrụ. ọrụ.Anyị ga-echere gị na CPHI Shanghai ngosi, ụlọ ntu N2F52.
Oge nzipu: Jun-26-2023